N-terminal-pro brain natriuretic peptide may be a useful biomarker for both mortality and respiratory exacerbations in pediatric patients with pulmonary hypertension.
Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.
Mothers of infants with congenital heart defects may be more likely to have cardiovascular hospitalizations.
Fewer cases of sudden infant death syndrome may be linked to genetic heart diseases than previously thought.
The FDA has approved a new size of the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff for use in newborn patients with heart defects.
Younger gestational age, longer postoperative duration of stay, and a confirmed genetic anomaly were associated with hearing loss after pediatric cardiac surgery.
Pediatric patients undergoing cardiac surgery who were from the lowest-income neighborhoods had increased mortality compared with children from the highest-income neighborhoods.
Only approximately half of pediatric patients with a blood pressure reading ≥95th percentile would be correctly classified based on BP reading.
In a recent study, implantable cardioverter-defibrillators treated sustained ventricular arrhythmias, including shocks and antitachycardia.
A pilot study will assess the effectiveness of milrinone in a small group of infants born with congenital diaphragmatic hernia.
Mandatory congenital heart disease screening in newborns was associated with a reduction in number of infant cardiac deaths.
Intrauterine exposure to methylphenidate is associated with an increase risk of congenital heart defects.
Primary care providers and medical homes have a role to play in the management of pediatric patients with congenital heart disease.
Serum lipid profile changes were shown to occur within the first year of initiating antiretroviral therapy in children.
Phylloquinone intake affects left ventricular structure and function in adolescents.
Pulse oximetry plus cardiac auscultation is a reliable method for neonatal congenital heart disease screening.
Some adolescents including those at normal or mid-risk level based on their systolic blood pressure, have target organ damage.
A 9-year-old child had a sudden cardiac arrest after eating a large bite of food.
Some newborns in the US are not being screened for congenital heart disease or hearing loss.
Bosentan has been approved for use in pediatric pulmonary arterial hypertension in children aged 3 years or older.
The American Academy of Pediatrics has released updated clinical practice guidelines for the diagnosis and management of hypertension in children.
Family socioeconomic position linked to maximum carotid intima-media thickness in mid-childhood.
The cardiovascular risk factors of high systolic blood pressure, high serum total cholesterol, and smoking were independently associated with worse cognitive performance in midlife.
Children aged 15-19 years appear to have the greatest risk of developing lone atrial fibrillation.
The AHA's statement focused on the epidemiology, genetics, pathogenesis, and long-term outcomes of Kawasaki disease.
All arrhythmic episodes were successfully converted, and no deaths were reported.
More than 40% of adolescents were found to have prehypertension or hypertension associated with higher body mass index.
Antihypertensive use in the month prior to conception through the third month of pregnancy resulted in an increased risk for congenital heart defects.
The majority of children diagnosed with definite arteriopathy and presenting with dissection and transient cerebral arteriopathy of childhood had headache complaints.
Patients with higher blood pressure trajectories also had thicker carotid intima-media thickness and increased LV mass index.
The Cardiology Advisor Articles
- The Connection Between Cardiovascular Disease and Sleep Apnea: An Expert Interview
- The Mounting Evidence Against Electronic Cigarette Use
- Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients
- Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
- Clinical Case: Pregnant Woman Presents With Worsening Dyspnea
- Sacubitril/Valsartan vs Enalapril for Physical Activity Improvement in HFrEF
- Improved Outcomes With CABG vs PCI for Diabetes With LV Dysfunction
- Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Cardiovascular Complications of COPD